These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [THE MYELOPROLIFERATIVE SYNDROME FROM THE VIEWPOINT OF CLINICAL HEMATOLOGISTS]. KUNZ G Z Gesamte Inn Med; 1964 Dec; 19():SUPPL:194-7. PubMed ID: 14235899 [No Abstract] [Full Text] [Related]
11. Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction. Oppliger Leibundgut E; Brunold C; Marti D; Horn MP; Seiler C; Schroeder V; Schmid JP; Tobler A; Zwicky C Haematologica; 2005 Jul; 90(7):875-80. PubMed ID: 15996924 [TBL] [Abstract][Full Text] [Related]
12. [THE PLACE OF OSTEOMYELOSCLEROSIS AMONG THE MYELOPROLIFERATIVE DISEASES]. STOBBE H Dtsch Gesundheitsw; 1965 Jan; 20():13-20. PubMed ID: 14265017 [No Abstract] [Full Text] [Related]
13. [Erythropoietic rate measured by ferrokinetics]. Montz R Nucl Med (Stuttg); 1970 Mar; 9(1):50-61. PubMed ID: 5505733 [No Abstract] [Full Text] [Related]
14. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia]. Iványi JL; Marton E; Plander M Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365 [TBL] [Abstract][Full Text] [Related]
15. Intracellular growth factors in polycythemia vera and other myeloproliferative disorders. Eid J; Ebert RF; Gesell MS; Spivak JL Proc Natl Acad Sci U S A; 1987 Jan; 84(2):532-6. PubMed ID: 3467372 [TBL] [Abstract][Full Text] [Related]
16. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. Goetzl EJ; An S; Smith WL FASEB J; 1995 Aug; 9(11):1051-8. PubMed ID: 7649404 [TBL] [Abstract][Full Text] [Related]
17. The Development and Use of Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms. Hobbs GS; Rozelle S; Mullally A Hematol Oncol Clin North Am; 2017 Aug; 31(4):613-626. PubMed ID: 28673391 [TBL] [Abstract][Full Text] [Related]
19. Intratracheal dosing with disodium cromoglycate inhibits late asthmatic response by attenuating eicosanoid production in guinea pigs. Nabe T; Yamamoto M; Suga M; Kohno S Eur J Pharmacol; 2004 Aug; 497(1):97-104. PubMed ID: 15321740 [TBL] [Abstract][Full Text] [Related]